UBS Group AG Buys 4,594 Shares of Invuity, Inc. (IVTY)
UBS Group AG increased its position in shares of Invuity, Inc. (NASDAQ:IVTY) by 53.4% during the first quarter, Holdings Channel reports. The institutional investor owned 13,200 shares of the medical instruments supplier’s stock after buying an additional 4,594 shares during the period. UBS Group AG’s holdings in Invuity were worth $105,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of IVTY. FMR LLC raised its stake in shares of Invuity by 0.5% in the first quarter. FMR LLC now owns 829,564 shares of the medical instruments supplier’s stock worth $6,595,000 after buying an additional 4,264 shares during the period. Dialectic Capital Management LP raised its stake in shares of Invuity by 67.7% in the first quarter. Dialectic Capital Management LP now owns 394,000 shares of the medical instruments supplier’s stock worth $3,132,000 after buying an additional 159,000 shares during the period. Granite Investment Partners LLC raised its stake in shares of Invuity by 90.4% in the first quarter. Granite Investment Partners LLC now owns 275,320 shares of the medical instruments supplier’s stock worth $2,189,000 after buying an additional 130,724 shares during the period. Bank of Montreal Can acquired a new stake in shares of Invuity during the first quarter worth approximately $112,000. Finally, Wesbanco Bank Inc. acquired a new stake in shares of Invuity during the first quarter worth approximately $493,000. Institutional investors own 70.06% of the company’s stock.
Shares of Invuity, Inc. (NASDAQ IVTY) traded up 0.81% during mid-day trading on Monday, hitting $6.25. The company’s stock had a trading volume of 21,306 shares. The company’s market cap is $106.56 million. The stock’s 50 day moving average price is $7.28 and its 200 day moving average price is $7.59. Invuity, Inc. has a 52-week low of $4.50 and a 52-week high of $14.25.
Invuity (NASDAQ:IVTY) last announced its earnings results on Tuesday, July 25th. The medical instruments supplier reported ($0.61) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.54) by $0.07. Invuity had a negative return on equity of 140.69% and a negative net margin of 114.61%. The company had revenue of $9.77 million during the quarter, compared to the consensus estimate of $10.30 million. Equities analysts forecast that Invuity, Inc. will post ($2.38) EPS for the current year.
COPYRIGHT VIOLATION WARNING: This piece was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/14/ubs-group-ag-buys-4594-shares-of-invuity-inc-ivty.html.
A number of brokerages recently commented on IVTY. Northland Securities reiterated a “buy” rating and set a $13.00 price target on shares of Invuity in a report on Monday, May 8th. Zacks Investment Research lowered Invuity from a “hold” rating to a “sell” rating in a report on Monday, May 1st. Stifel Nicolaus reiterated a “buy” rating and set a $10.00 price target (up from $9.00) on shares of Invuity in a report on Thursday, April 27th. Piper Jaffray Companies reiterated a “buy” rating and set a $10.00 price target on shares of Invuity in a report on Wednesday, July 26th. Finally, William Blair reiterated a “buy” rating on shares of Invuity in a report on Tuesday, May 23rd. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $15.17.
In related news, Director Eric W. Roberts bought 6,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 18th. The shares were bought at an average cost of $7.07 per share, with a total value of $45,955.00. Following the acquisition, the director now owns 106,029 shares in the company, valued at $749,625.03. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 10.50% of the stock is currently owned by company insiders.
Want to see what other hedge funds are holding IVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invuity, Inc. (NASDAQ:IVTY).
Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.